Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia
Hossein Ayatollahi, Arezoo Shajiei, Mohammad Hadi Sadeghian, et al.
Hematology/Oncology and Stem Cell Therapy (2016) Vol. 10, Iss. 1, pp. 1-7
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Jenna L. Carter, Katie Hege, Jay Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 166
Unified classification and risk-stratification in Acute Myeloid Leukemia
Yanis Tazi, Juan E. Arango‐Ossa, Yangyu Zhou, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 114
Definition of a small core transcriptional circuit regulated by AML1-ETO
Kristy R. Stengel, Jacob Ellis, Clare Spielman, et al.
Molecular Cell (2020) Vol. 81, Iss. 3, pp. 530-545.e5
Open Access | Times Cited: 63
Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions
Katharina Rothe, Vanessa Porter, Xiaoyan Jiang
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 461-461
Open Access | Times Cited: 61
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool
Sara Galimberti, Serena Balducci, Francesca Guerrini, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1305-1305
Open Access | Times Cited: 29
Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
Siyu Gu, Yue Hou, Katarina Dovat, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
Sook‐Kyoung Heo, Eui‐Kyu Noh, Jeong Yi Kim, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 61
Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia
Katherine Tarlock, Todd A. Alonzo, Yi-Cheng Wang, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 16, pp. 5038-5048
Open Access | Times Cited: 49
Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline
Valérie de Haas, Nofisat Ismaila, Anjali S. Advani, et al.
Journal of Clinical Oncology (2018) Vol. 37, Iss. 3, pp. 239-253
Open Access | Times Cited: 42
D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations
Shunsuke Yui, Saiko Kurosawa, Hiroki Yamaguchi, et al.
Annals of Hematology (2017) Vol. 96, Iss. 10, pp. 1641-1652
Closed Access | Times Cited: 41
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3429-3429
Open Access | Times Cited: 39
Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia
Timofey Lebedev, Elmira Vagapova, В. И. Попенко, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 39
Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study
Heesun J. Rogers, Xiaoqiong Wang, Yan Xie, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 7, pp. 799-808
Open Access | Times Cited: 36
WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts
Lin Jiang, Jingjing Zheng, Johnny S. H. Kwan, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 16, pp. e96-e96
Open Access | Times Cited: 31
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia
Jayastu Senapati, Mahran Shoukier, Guillermo Garcia‐Manero, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 5, pp. 574-582
Open Access | Times Cited: 19
c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights
Mona S. Abdellateif, Ahmed Bayoumi, Mohammed Mohammed
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 785-799
Open Access | Times Cited: 10
Functional Role of Fatty Acid Synthase for Signal Transduction in Core-Binding Factor Acute Myeloid Leukemia with an Activating c-Kit Mutation
Ruimeng Zhuang, Bente Siebels, Konstantin Hoffer, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 619-619
Open Access
Advances in therapeutic options for newly diagnosed, high-risk AML patients
Kimberley Doucette, Judith E. Karp, Catherine Lai
Therapeutic Advances in Hematology (2021) Vol. 12
Open Access | Times Cited: 21
CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia
Adam Nopora, Ulrich H. Weidle
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 2, pp. 118-136
Open Access | Times Cited: 3
Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia
Mihir Shukla, Maher Abdul‐Hay, Jun‐Hui Choi
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1768-1768
Open Access | Times Cited: 3
Comparison of the Kinase Profile of Midostaurin (Rydapt) with That of Its Predominant Metabolites and the Potential Relevance of Some Newly Identified Targets to Leukemia Therapy
Paul W. Manley, Giorgio Caravatti, Pascal Furet, et al.
Biochemistry (2018) Vol. 57, Iss. 38, pp. 5576-5590
Closed Access | Times Cited: 24
Loss of X chromosome predicts favorable prognosis in female patients with t(8;21) acute myeloid leukemia
Guofeng Chen, Wei Zhou, Dan Gong, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2020) Vol. 61, Iss. 5, pp. 1168-1177
Closed Access | Times Cited: 22
Straight to the Point—The Novel Strategies to Cure Pediatric AML
Monika Lejman, Izabela Dziatkiewicz, Mateusz Jurek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1968-1968
Open Access | Times Cited: 13
The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment
Christina Darwish, Kyle Farina, Douglas Tremblay
Blood Reviews (2023) Vol. 62, pp. 101117-101117
Closed Access | Times Cited: 8
An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances
Valentina Tateo, Lisa Manuzzi, Claudia Parisi, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 316-316
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top